TY - JOUR
T1 - Blue-light imaging has an additional value to white-light endoscopy in visualization of early Barrett's neoplasia
T2 - an international multicenter cohort study
AU - de Groof, Albert J.
AU - Swager, Anne Fré
AU - Pouw, Roos E.
AU - Weusten, Bas L.A.M.
AU - Schoon, Erik J.
AU - Bisschops, Raf
AU - Pech, Oliver
AU - Meining, Alexander
AU - Neuhaus, Horst
AU - Curvers, Wouter L.
AU - Bergman, Jacques J.G.H.M.
N1 - Funding Information:
This study was supported by an unrestricted research grant from FUJIFILM Europe (FUJIFILM Europe GmbH, D?sseldorf, Germany), which had no involvement in the design, recruitment, data collection, analysis or interpretation, or writing of the manuscript. DISCLOSURE: All authors disclosed no financial relationships relevant to this publication.
Funding Information:
This study was supported by an unrestricted research grant from FUJIFILM Europe (FUJIFILM Europe GmbH, Düsseldorf, Germany), which had no involvement in the design, recruitment, data collection, analysis or interpretation, or writing of the manuscript.
Publisher Copyright:
© 2019 American Society for Gastrointestinal Endoscopy
PY - 2019/4/1
Y1 - 2019/4/1
N2 - BACKGROUND AND AIMS: Endoscopic features of early neoplasia in Barrett's esophagus (BE) are subtle. Blue-light imaging (BLI) may improve visualization of neoplastic lesions. The aim of this study was to evaluate BLI in visualization of Barrett's neoplasia.METHODS: Corresponding white-light endoscopy (WLE) and BLI images of 40 BE lesions were obtained prospectively and assessed by 6 international experts in 3 assessments. Each assessment consisted of overview and magnification images. Assessments were as follows: assessment 1, WLE only; assessment 2, BLI only; and assessment 3, corresponding WLE and BLI images. Outcome parameters were as follows: (1) appreciation of macroscopic appearance and surface relief (visual analog scale scores); (2) ability to delineate lesions (visual analog scale scores); (3) preferred technique for delineation (ordinal scores); and (4) quantitative agreement on delineations (AND/OR scores).RESULTS: Experts appreciated BLI significantly better than WLE for visualization of macroscopic appearance (median 8.0 vs 7.0, P < .001) and surface relief (8.0 vs 6.0, P < .001). For both overview and magnification images, experts appreciated BLI significantly better than WLE for ability to delineate lesions (8.0 vs 6.0, P < .001 and 8.0 vs 5.0, P < .001). There was no overall significant difference in AND/OR scores of WLE + BLI when compared with WLE, yet agreement increased significantly with WLE + BLI for cases with a low baseline AND/OR score on WLE, both in overview (mean difference, 0.15; P = .015) and magnification (mean difference, 0.10; P = .01).CONCLUSIONS: BLI has additional value for visualization of BE neoplasia. Experts appreciated BLI better than WLE for visualization and delineation of BE neoplasia. Quantitative agreement increased significantly when BLI was offered next to WLE for lesions that were hard to delineate with WLE alone. (ISRCTN registry study ID: ISRCTN15916689.).
AB - BACKGROUND AND AIMS: Endoscopic features of early neoplasia in Barrett's esophagus (BE) are subtle. Blue-light imaging (BLI) may improve visualization of neoplastic lesions. The aim of this study was to evaluate BLI in visualization of Barrett's neoplasia.METHODS: Corresponding white-light endoscopy (WLE) and BLI images of 40 BE lesions were obtained prospectively and assessed by 6 international experts in 3 assessments. Each assessment consisted of overview and magnification images. Assessments were as follows: assessment 1, WLE only; assessment 2, BLI only; and assessment 3, corresponding WLE and BLI images. Outcome parameters were as follows: (1) appreciation of macroscopic appearance and surface relief (visual analog scale scores); (2) ability to delineate lesions (visual analog scale scores); (3) preferred technique for delineation (ordinal scores); and (4) quantitative agreement on delineations (AND/OR scores).RESULTS: Experts appreciated BLI significantly better than WLE for visualization of macroscopic appearance (median 8.0 vs 7.0, P < .001) and surface relief (8.0 vs 6.0, P < .001). For both overview and magnification images, experts appreciated BLI significantly better than WLE for ability to delineate lesions (8.0 vs 6.0, P < .001 and 8.0 vs 5.0, P < .001). There was no overall significant difference in AND/OR scores of WLE + BLI when compared with WLE, yet agreement increased significantly with WLE + BLI for cases with a low baseline AND/OR score on WLE, both in overview (mean difference, 0.15; P = .015) and magnification (mean difference, 0.10; P = .01).CONCLUSIONS: BLI has additional value for visualization of BE neoplasia. Experts appreciated BLI better than WLE for visualization and delineation of BE neoplasia. Quantitative agreement increased significantly when BLI was offered next to WLE for lesions that were hard to delineate with WLE alone. (ISRCTN registry study ID: ISRCTN15916689.).
KW - Adenocarcinoma/diagnostic imaging
KW - Barrett Esophagus/diagnostic imaging
KW - Cohort Studies
KW - Esophageal Neoplasms/diagnostic imaging
KW - Esophagoscopy/methods
KW - Humans
KW - Optical Imaging/methods
KW - Precancerous Conditions/diagnostic imaging
KW - Prospective Studies
UR - http://www.scopus.com/inward/record.url?scp=85059128368&partnerID=8YFLogxK
U2 - 10.1016/j.gie.2018.10.046
DO - 10.1016/j.gie.2018.10.046
M3 - Article
C2 - 30419218
AN - SCOPUS:85059128368
SN - 0016-5107
VL - 89
SP - 749
EP - 758
JO - Gastrointestinal Endoscopy
JF - Gastrointestinal Endoscopy
IS - 4
ER -